Multiple sclerosis and Organising pneumonia

Summary:

Organising pneumonia is found among people with Multiple sclerosis, especially for people who are female, 60+ old.

The study analyzes which people have Organising pneumonia with Multiple sclerosis. It is created by eHealthMe based on reports of 50 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Multiple sclerosis?

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,088 drugs and 1,358 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.

What is Organising pneumonia?

Organising pneumonia (pathologically by the presence in the distal air spaces of buds of granulation tissue) is found to be associated with 441 drugs and 487 conditions by eHealthMe. Check the latest studies of Organising pneumonia.

On Jul, 05, 2026

50 people who have Multiple Sclerosis and Organising Pneumonia are studied.

Would you have Organising pneumonia when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experienced Organising Pneumonia *:

female: 81.63 %
male: 18.37 %

Age of people who have Multiple Sclerosis and experienced Organising Pneumonia *:

Common co-existing conditions for these people *:

Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 2.00%
Rickets (softening of bones): 1 person, 2.00%
Restless Leg Syndrome (a powerful urge to move your legs): 1 person, 2.00%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 2.00%
Depression: 1 person, 2.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 2.00%
Balance Disorder: 1 person, 2.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Influenza Like Illness: 6 people, 12.00%
Diabetes: 4 people, 8.00%
Alveolitis Allergic (inflammation of the alveoli within the lung caused by hypersensitivity to inhaled organic dusts): 3 people, 6.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 6.00%
Weight Increased: 2 people, 4.00%
Post Procedural Haemorrhage (post procedural bleeding): 2 people, 4.00%
Cellulitis (infection under the skin): 2 people, 4.00%
Coronary Artery Stenosis (narrowing of coronary artery): 2 people, 4.00%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 4.00%
Fever: 2 people, 4.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Organising pneumonia?

- Check whether Organising pneumonia is associated with a drug or a condition

Related publications that referenced our studies

Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Organising pneumonia and Multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.